P, K., VW, W., L, E., A, N., B, L., KK, M., & PA, d. A. (2024). Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group. Pediatric blood & cancer, 71(7), e31039. https://doi.org/10.1002/pbc.31039
Chicago Style (17th ed.) CitationP, Kumar, Willard VW, Embry L, Naranjo A, LaBarre B, Matthay KK, and de Alarcon PA. "Late Cognitive and Adaptive Outcomes of Patients with Neuroblastoma-associated Opsoclonus-myoclonus-ataxia-syndrome: A Report from the Children's Oncology Group." Pediatric Blood & Cancer 71, no. 7 (2024): e31039. https://doi.org/10.1002/pbc.31039.
MLA (9th ed.) CitationP, Kumar, et al. "Late Cognitive and Adaptive Outcomes of Patients with Neuroblastoma-associated Opsoclonus-myoclonus-ataxia-syndrome: A Report from the Children's Oncology Group." Pediatric Blood & Cancer, vol. 71, no. 7, 2024, p. e31039, https://doi.org/10.1002/pbc.31039.